A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.
- Status
- RECRUITING
- Phase
- PHASE3
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
- Status
- COMPLETED
- Phase
- N/A
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Comparing of With and Without Sequential Therapy of S-1
- Status
- RECRUITING
- Phase
- PHASE3
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer
- Status
- RECRUITING
- Phase
- NA
Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
- Status
- COMPLETED
- Phase
- N/A
Study With Various Immunotherapy Treatments in Participants With Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
- Status
- RECRUITING
- Phase
- PHASE3
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2